An Analysis of Price Discrimination in Brand Name Drug Wholesaling

Richard Frank, Raymond Hartman and Benjamin Sommers

International Journal of the Economics of Business, 2007, vol. 14, issue 3, pages 299-315

Abstract: Accounting measures of profitability are viewed by the academic literature with skepticism, perhaps even disdain. Accounting information and accounting rates of return are, however, relied upon extensively by market participants to compare and contrast the economic performance of alternative investments, alternative companies and alternative industries, at a single point in time and over time. We believe that accounting information and accounting measures of profitability can be useful under specific conditions. We agree that important concerns do arise about the appropriateness of accounting measures for certain analyses. However, one can take these concerns too far. We describe one such situation - one involving an antitrust complaint of price discrimination in a particular network industry - wholesaling in pharmaceutical product markets.

Keywords: Network Industry; Accounting Data; Prescription Data; Antitrust (search for similar items in EconPapers)
Date: 2007

Downloads: (external link)
http://www.informaworld.com/openurl?genre=article& ... 40C6AD35DC6213A474B5 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:taf:ijecbs:v:14:y:2007:i:3:p:299-315

Ordering information: This journal article can be ordered from
http://www.tandf.co.uk/journals/subscription.html

Access Statistics for this article

International Journal of the Economics of Business is edited by Eleanor Morgan and H.E. Frech

More articles in International Journal of the Economics of Business from Taylor and Francis Journals
Series data maintained by Christopher F. Baum ().